George W. Wright
Impact in
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
Papers in
-
- Lymphoma Diagnosis and Treatment 93
-
- NF-κB Signaling Pathways 10
- MicroRNA in disease regulation 4
- Co-authors
- Louis M. Staudt (42 shared papers)Andreas Rosenwald (13 shared papers)Wyndham Hopkins Wilson (11 shared papers)Bruce K. Tan (2 shared papers)Adrian U. Wiestner (1 shared paper)Giles F. Filley (4 shared papers)Elaine S. Jaffe (12 shared papers)Sandeep S. Davé (4 shared papers)
- Journals
- Blood (38 papers)Cancer Cell (14 papers)Proceedings of the National Academy of Sciences (9 papers)New England Journal of Medicine (7 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
George W. Wright
139 papers receiving 29.3k citations
George W. Wright's Hit Papers
Peers
Comparison fields: 5 of 134
- Pathology and Forensic Medicine 17.7k
- Cancer Research 2.5k
- Genetics 1.6k
- Oncology 2.5k
- Hematology 1.2k
Countries citing papers authored by George W. Wright
This map shows the geographic impact of George W. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George W. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George W. Wright more than expected).
Fields of papers citing papers by George W. Wright
This network shows the impact of papers produced by George W. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George W. Wright. The network helps show where George W. Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside George W. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma Hit paper breakdown → | 2002 | 3137 |
| 2 | Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma Hit paper breakdown → | 2018 | 1697 |
| 3 | Stromal Gene Signatures in Large-B-Cell Lymphomas Hit paper breakdown → | 2008 | 1476 |
| 4 | Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma Hit paper breakdown → | 2010 | 1375 |
| 5 | Oncogenically active MYD88 mutations in human lymphoma Hit paper breakdown → | 2010 | 1243 |
| 6 | Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells Hit paper breakdown → | 2004 | 1134 |
| 7 | Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma Hit paper breakdown → | 2015 | 964 |
| 8 | Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma Hit paper breakdown → | 2003 | 871 |
| 9 | A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications Hit paper breakdown → | 2020 | 847 |
| 10 | A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma Hit paper breakdown → | 2003 | 843 |
| 11 | Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma Hit paper breakdown → | 2007 | 822 |
| 12 | Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Hit paper breakdown → | 2012 | 810 |
| 13 | Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways Hit paper breakdown → | 2008 | 805 |
| 14 | The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma Hit paper breakdown → | 2003 | 737 |
| 15 | Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma Hit paper breakdown → | 2008 | 729 |
| 16 | Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics Hit paper breakdown → | 2012 | 708 |
| 17 | Molecular Diagnosis of Burkitt's Lymphoma Hit paper breakdown → | 2006 | 684 |
| 18 | IRF4 addiction in multiple myeloma Hit paper breakdown → | 2008 | 597 |
| 19 | Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue Hit paper breakdown → | 2014 | 521 |
| 20 | Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma Hit paper breakdown → | 2012 | 437 |
About George W. Wright
George W. Wright is a scholar working on Pathology and Forensic Medicine, Cancer Research, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 143 papers that have together received 30.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (93 papers), NF-κB Signaling Pathways (10 papers), Gene expression and cancer classification (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Multiple Myeloma Research and Treatments (4 papers), Respiratory Support and Mechanisms (4 papers), MicroRNA in disease regulation (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (17.7k citations), Cancer Research (2.5k citations), Genetics (1.6k citations), Oncology (2.5k citations) and Hematology (1.2k citations). George W. Wright has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Louis M. Staudt, Andreas Rosenwald, Wyndham Hopkins Wilson, Bruce K. Tan, Adrian U. Wiestner, Giles F. Filley, Elaine S. Jaffe, Sandeep S. Davé, Da Wei Huang and Arthur L. Shaffer. Their work appears in journals such as Blood, Cancer Cell, Proceedings of the National Academy of Sciences, New England Journal of Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.